Literature DB >> 1931864

Induction of cytokine production from human monocytes stimulated with alginate.

M Otterlei1, K Ostgaard, G Skjåk-Braek, O Smidsrød, P Soon-Shiong, T Espevik.   

Abstract

Alginates are polysaccharides with gel-forming properties composed of 1,4-linked beta-D-mannuronic acid (M), alpha-L-guluronic acid (G), and alternating (MG) blocks. Alginate can be used as a matrix for implanted cells in vivo. In this study, we have examined the ability of alginates and their components to stimulate human monocytes to produce tumor necrosis factor-alpha, interleukin-6, and interleukin-1. Alginates stimulated the monocytes to produce high levels of all three cytokines. Low G alginates were approximately 10 times more potent in inducing cytokine production compared with high G alginates. The M-blocks and the MG-blocks, but not the G-blocks, stimulated the cytokine production. The results demonstrate that the mannuronic acid residues are the active cytokine inducers in alginates.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1931864     DOI: 10.1097/00002371-199108000-00007

Source DB:  PubMed          Journal:  J Immunother (1991)        ISSN: 1053-8550


  41 in total

1.  Alginate: properties and biomedical applications.

Authors:  Kuen Yong Lee; David J Mooney
Journal:  Prog Polym Sci       Date:  2012-01       Impact factor: 29.190

2.  Cloning and expression of three new Aazotobacter vinelandii genes closely related to a previously described gene family encoding mannuronan C-5-epimerases.

Authors:  B I Svanem; G Skjåk-Braek; H Ertesvåg; S Valla
Journal:  J Bacteriol       Date:  1999-01       Impact factor: 3.490

3.  Accelerated healing of cutaneous leishmaniasis in non-healing BALB/c mice using water soluble amphotericin B-polymethacrylic acid.

Authors:  Karina Corware; Debra Harris; Ian Teo; Matthew Rogers; Kikkeri Naresh; Ingrid Müller; Sunil Shaunak
Journal:  Biomaterials       Date:  2011-07-31       Impact factor: 12.479

Review 4.  Islet transplantation and encapsulation: an update on recent developments.

Authors:  Vijayaganapathy Vaithilingam; Bernard E Tuch
Journal:  Rev Diabet Stud       Date:  2011-05-10

Review 5.  Stem cell microencapsulation for phenotypic control, bioprocessing, and transplantation.

Authors:  Jenna L Wilson; Todd C McDevitt
Journal:  Biotechnol Bioeng       Date:  2013-01-17       Impact factor: 4.530

6.  Vaccine-like controlled-release delivery of an immunomodulating peptide to treat experimental autoimmune encephalomyelitis.

Authors:  Barlas Büyüktimkin; Qun Wang; Paul Kiptoo; John M Stewart; Cory Berkland; Teruna J Siahaan
Journal:  Mol Pharm       Date:  2012-03-13       Impact factor: 4.939

7.  Enhancing effect of glucose microspheres in the viability of human mesenchymal stem cell suspensions for clinical administration.

Authors:  Patricia Gálvez; Maria J Martín; Ana C Calpena; Juan A Tamayo; Maria A Ruiz; Beatriz Clares
Journal:  Pharm Res       Date:  2014-06-25       Impact factor: 4.200

Review 8.  Islet and stem cell encapsulation for clinical transplantation.

Authors:  Rahul Krishnan; Michael Alexander; Lourdes Robles; Clarence E Foster; Jonathan R T Lakey
Journal:  Rev Diabet Stud       Date:  2014-05-10

Review 9.  Inorganic nanoporous membranes for immunoisolated cell-based drug delivery.

Authors:  Adam Mendelsohn; Tejal Desai
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

10.  Magnetization transfer contrast MRI for non-invasive assessment of innate and adaptive immune responses against alginate-encapsulated cells.

Authors:  Kannie W Y Chan; Guanshu Liu; Peter C M van Zijl; Jeff W M Bulte; Michael T McMahon
Journal:  Biomaterials       Date:  2014-06-13       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.